Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 23, 2022, Royalty Pharma plc (the "Company") held its annual general meeting of shareholders (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders voted on eight proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2022 (the "Proxy Statement"). There were 526,202,058 shares of the Company's Class A ordinary shares and Class B ordinary shares, voting as a single class, present or represented by proxy at the Annual Meeting, which represented 86.66% of the combined voting power of the Class A ordinary shares and Class B ordinary shares entitled to vote at the Annual Meeting, and which constituted a quorum for the transaction of business. Holders of the Company's Class A ordinary shares and Class B ordinary shares were entitled to one vote for each share held as of the record date described in the Proxy Statement. The Company's inspector of election certified the following vote tabulations:



Proposal 1. To elect ten directors, each by separate ordinary resolutions, to
the Company's Board of Directors to serve until the 2023 Annual General Meeting
of Shareholders:

Nominee                    For           Against     Abstain   Broker Non-Votes
Pablo Legorreta         497,914,793     3,944,560    708,929      23,633,776
Henry Fernandez         449,842,039     52,646,198   80,045       23,633,776
Bonnie Bassler          499,708,038     2,803,511    56,733       23,633,776
Errol De Souza          460,164,216     42,322,200   81,866       23,633,776
Catherine Engelbert     449,908,673     52,601,787   57,822       23,633,776
M. Germano Giuliani     502,093,226      394,642     80,414       23,633,776
David Hodgson           501,640,083      847,462     80,737       23,633,776
Ted Love                461,158,768     41,329,460   80,054       23,633,776
Gregory Norden          438,098,917     64,389,500   79,865       23,633,776
Rory Riggs              501,544,818     1,007,592    15,872       23,633,776

Proposal 2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers:

For Against Abstain Broker Non-Votes 480,577,839 21,850,442 140,001 23,633,776

Proposal 3. To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm:



    For       Against   Abstain
525,768,280   247,335   186,443

There were no broker non-votes on this proposal.

Proposal 4. To approve receipt of the Company's U.K. statutory accounts together with the Company's U.K. statutory reports, including the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the fiscal year ended December 31, 2021 ("U.K. Annual Report and Accounts"):



    For       Against   Abstain   Broker Non-Votes
501,932,527   84,391    551,364      23,633,776

--------------------------------------------------------------------------------

Proposal 5. To approve, on a non-binding advisory basis, the Company's U.K. directors' remuneration report in the U.K. Annual Report and Accounts:

For Against Abstain Broker Non-Votes 482,274,121 20,193,345 100,816 23,633,776

Proposal 6. To re-appoint Ernst & Young Chartered Accountants as the Company's U.K. statutory auditor under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. annual report and accounts are presented to shareholders:



    For       Against   Abstain
525,179,922   833,504   188,632

There were no broker non-votes on this proposal.

Proposal 7. To authorize the board of directors to determine the remuneration of the Company's U.K. statutory auditor:

For Against Abstain Broker Non-Votes 502,036,049 464,254 67,979 23,633,776

Proposal 8. To approve the terms of the agreements and counterparties pursuant to which the Company may purchase its Class A ordinary shares:

For Against Abstain Broker Non-Votes 501,270,812 1,083,144 214,326 23,633,776

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses